The reductive activation of the antitumor drug RH1 to its semiquinone free radical by NADPH cytochrome P450 reductase and by HCT116 human colon cancer cells

Author: Hasinoff Brian B.   begleiter Asher  

Publisher: Informa Healthcare

ISSN: 1071-5762

Source: Free Radical Research, Vol.40, Iss.9, 2006-09, pp. : 974-978

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content